Nishioka Tomoki, Soemantri Augustinus, Ishida Takafumi
Human Biology and Genetics, Department of Biological Sciences, Graduate School of Science, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Faculty of Medicine, Diponegoro University, Semarang, Indonesia.
J Hum Genet. 2004;49(12):701-705. doi: 10.1007/s10038-004-0209-5. Epub 2004 Nov 16.
Leber's hereditary optic neuropathy (LHON) is a maternally inherited disease caused by mitochondrial DNA (mtDNA) mutations. In this study, the mtDNA/nuclear DNA ratio was evaluated in 11 LHON patients with the 14484 mutation, 13 asymptomatic carriers and 18 non-carrier relatives as controls, to reveal possible relationships between the disease and mtDNA content. DNAs from peripheral blood lymphocytes were subjected to quantitative PCR. Gender differences and age-dependent changes in the mtDNA content were not observed. Significant increase in the mtDNA content was observed only in the asymptomatic carriers (P<0.05). This indicated that individuals whose mtDNA content had increased and been maintained at certain levels were free from LHON development, whereas those whose levels had not, had developed LHON. Since the asymptomatic carriers are the stock of the future LHON patients, monitoring the mtDNA content in patients and their relatives may help to predict the prognosis of the disease.
Leber遗传性视神经病变(LHON)是一种由线粒体DNA(mtDNA)突变引起的母系遗传性疾病。在本研究中,对11例携带14484突变的LHON患者、13例无症状携带者以及18例作为对照的非携带者亲属进行了mtDNA/核DNA比例评估,以揭示该疾病与mtDNA含量之间可能存在的关系。对外周血淋巴细胞的DNA进行了定量PCR检测。未观察到mtDNA含量存在性别差异和年龄依赖性变化。仅在无症状携带者中观察到mtDNA含量显著增加(P<0.05)。这表明mtDNA含量增加并维持在一定水平的个体未发生LHON,而未达到该水平的个体则发生了LHON。由于无症状携带者是未来LHON患者的来源,监测患者及其亲属的mtDNA含量可能有助于预测该疾病的预后。